Life Sciences

This issue of Vital Signs, released on May 28, 2013, provides an insight in to medical image management. Additionally, a company spotlight is provided for Cloud-Based Image Exchange. Image exchange provides a good case in point of the recent evolution of cloud-based applications in imaging. Image exchange is only a small subset of the larger appl...

Basal media, fetal bovine media, and balanced salt solutions are prevalent cell culture media. However, serum free media and growth, as well as attachment factors, are expected to see increased use in 2013 because current non-users are planning to include them in their workflow. Overall, Asia-Pacific is still a growing market in terms of the numbe...

Picture archiving and communication systems, commonly known as PACS, have only recently gained ground in the Malaysian healthcare delivery system. Given the comparatively small installed base in this country and the technologys need to be updated every 3 to 5 years, the Malaysian market presents significant opportunities for PACS vendors. This rese...

The Chinese pharmaceutical market is expected to be the third-largest in the world in 2013. This research service analyzes various aspects of the Chinese pharmaceutical market between 2007 and 2016. Rising income, improving healthcare infrastructure, and insurance systems are some factors that drive this market. The study discusses in detail the ma...

This research service focuses on insulin and non-insulin therapeutics for the treatment of type 1 and 2 diabetes in Latin America. The insulin and non-insulin markets will experience major changes within the next three years, due to the discovery of new drugs. Focus is currently placed on the development of molecules that can help with patients ad...

The study analyses the Turkish healthcare landscape, market outlook and growth opportunities by covering private healthcare services, pharmaceuticals, medical devices, medical imaging and clinical diagnostics segments. Rapid economic growth and healthcare transformation program generated a significant increase in healthcare expenditure in Turkey. T...

This issue of Vital Signs, released on April 30, 2013, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences and Advanced Medical Technology.

This issue of Vital Signs discusses the acquisition of Cellular Research by Beckton Dickinson, collabaration of Illumina and Asuragen on companion diagnostics, a landmark NIH study on blood pressure management, and drug price hikes.

This research service analyzes the US general X-ray radiography imaging equipment market, which is transitioning toward more compact portable and modular digital technologies. The market segments evaluated are analog radiography, computed radiography (CR), and digital radiography (DR). The suites, mobiles, and retrofits sub-segments of the DR segme...